These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1535533

  • 1. Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
    Lisovoski F, Haby C, Borrelli E, Schleef C, Revel MO, Hindelang C, Zwiller J.
    Brain Res Bull; 1992 May; 28(5):697-701. PubMed ID: 1535533
    [Abstract] [Full Text] [Related]

  • 2. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M, Mennicken F, Chritin M, Abrous DN, Feuerstein C, Le Moal M, Herman JP.
    Neuroscience; 1992 May; 46(3):729-38. PubMed ID: 1532053
    [Abstract] [Full Text] [Related]

  • 3. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ, Dunnett SB, Northrop AJ, Morris BJ.
    Neuroscience; 1990 May; 37(3):757-66. PubMed ID: 2247221
    [Abstract] [Full Text] [Related]

  • 4. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ, Davenport AP, Sirinathsinghji DJ, Hall MD, Hill RG, Hughes J.
    Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
    [Abstract] [Full Text] [Related]

  • 5. A 6-hydroxydopamine-induced selective parkinsonian rat model.
    Perese DA, Ulman J, Viola J, Ewing SE, Bankiewicz KS.
    Brain Res; 1989 Aug 14; 494(2):285-93. PubMed ID: 2528389
    [Abstract] [Full Text] [Related]

  • 6. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 Aug 14; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

  • 7. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Sirinathsinghji DJ, Heavens RP, Richards SJ, Beresford IJ, Hall MD.
    Neuroscience; 1988 Oct 14; 27(1):117-28. PubMed ID: 3264391
    [Abstract] [Full Text] [Related]

  • 8. Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine.
    Chen JF, Qin ZH, Szele F, Bai G, Weiss B.
    Neuropharmacology; 1991 Sep 14; 30(9):927-41. PubMed ID: 1833662
    [Abstract] [Full Text] [Related]

  • 9. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C, Bédard PJ, Rioux L, Gaudin D, Martinoli MG, Pelletier G, Di Paolo T.
    Brain Res; 1991 Sep 06; 558(2):251-63. PubMed ID: 1838295
    [Abstract] [Full Text] [Related]

  • 10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 06; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 11. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
    Rioux L, Gaudin DP, Gagnon C, Di Paolo T, Bédard PJ.
    Neuroscience; 1991 Mar 06; 44(1):75-83. PubMed ID: 1770999
    [Abstract] [Full Text] [Related]

  • 12. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism.
    Friehs GM, Parker RG, He LS, Haines SJ, Turner DA, Ebner TJ.
    J Neural Transplant Plast; 1991 Mar 06; 2(2):141-56. PubMed ID: 1684115
    [Abstract] [Full Text] [Related]

  • 13. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
    Hefti F, Melamed E, Wurtman RJ.
    Brain Res; 1980 Aug 11; 195(1):123-37. PubMed ID: 6105003
    [Abstract] [Full Text] [Related]

  • 14. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat.
    Cadet JL, Zhu SM.
    Brain Res; 1992 Nov 13; 595(2):316-26. PubMed ID: 1467973
    [Abstract] [Full Text] [Related]

  • 15. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 16. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms.
    Robertson GS, Robertson HA.
    J Neurosci; 1989 Sep 10; 9(9):3326-31. PubMed ID: 2795165
    [Abstract] [Full Text] [Related]

  • 17. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M, Dubois A, Feuerstein C, Manier M, Scatton B.
    Neurosci Lett; 1987 Feb 24; 74(2):180-6. PubMed ID: 2883609
    [Abstract] [Full Text] [Related]

  • 18. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun 24; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 19. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E, Hefti F, Wurtman RJ.
    Isr J Med Sci; 1982 Jan 24; 18(1):159-63. PubMed ID: 6121770
    [Abstract] [Full Text] [Related]

  • 20. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Turgeon SM, Fink JS.
    Neuroscience; 1997 Jul 24; 79(1):79-93. PubMed ID: 9178866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.